In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Novartis pays $2.8bn for 20% of Roche's voting shares

Executive Summary

Novartis has purchased 32mm voting shares of Roche at $87.36 each (SFr151)--a (pr)5% premium-- from BZ Group Holdings for a total of $2.8bn (SFr4.83bn).
Deal Industry
  • In Vitro Diagnostics
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity

Related Companies